Nuwellis (NUWE) Capital Expenditures Growth (3y) (2014 - 2026)
Nuwellis (NUWE) Capital Expenditures Growth (3y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.07 Bn | 193.46 Bn | 7.27 Bn | -0.66% |
| 2 | Stryker | 127.90 Bn | 124.43 Bn | 4.50 Bn | 9.94% |
| 3 | Medtronic | 118.84 Bn | 109.62 Bn | 6.41 Bn | 8.89% |
| 4 | Boston Scientific | 73.33 Bn | 72.79 Bn | 3.85 Bn | 10.89% |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 11.78% |
| 6 | Dexcom | 34.46 Bn | 32.51 Bn | 830.00 Mn | 12.81% |
| 7 | GE HealthCare Technologies | 33.91 Bn | 31.81 Bn | 2.18 Bn | 12.62% |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | 19.51% |
| 9 | Steris | 23.12 Bn | 22.64 Bn | 684.20 Mn | 9.52% |
| 10 | Nuwellis | 204,804.59 | -3.72 Mn | 1.50 Mn | 53.09% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 53.09% |
| Mar 31, 2026 | 32.15% |
| Dec 31, 2025 | -38.06% |
| Sep 30, 2025 | 64.54% |
| Jun 30, 2025 | -28.62% |
| Dec 31, 2024 | -6.35% |
| Sep 30, 2024 | -31.93% |
| Jun 30, 2024 | -33.33% |
| Mar 31, 2024 | -19.70% |
| Dec 31, 2023 | -33.80% |
| Sep 30, 2023 | -4.29% |
| Jun 30, 2023 | -0.65% |
| Mar 31, 2023 | -8.55% |
| Dec 31, 2022 | -9.93% |
| Sep 30, 2022 | -58.42% |
| Jun 30, 2022 | -54.53% |
| Mar 31, 2022 | 19.52% |
| Dec 31, 2021 | 10.06% |
| Sep 30, 2021 | -1.20% |
| Jun 30, 2021 | 8.17% |